Physician profile

James Cochran

Boca Raton, FL

NPI 1245321124

$934.17

in general payments reported to CMS, 2019-2025

18 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $193.09 2020-2021
Novartis Pharmaceuticals Corporation $192.14 2019-2021
Celgene Corporation $137.20 2021-2022
Genzyme Corporation $111.50 2021-2022
Lundbeck LLC $43.15 2019-2022
Teva Pharmaceuticals USA, INC. $28.51 2019
Abbvie INC. $26.50 2021-2022
E.R. Squibb & Sons, L.L.C. $25.99 2021
Merz North America, INC. $25.60 2019
Acorda Therapeutics, INC $22.19 2019
Biogen, INC. $19.82 2020
Upsher-Smith Laboratories LLC $17.70 2020
Medtronic Vascular, INC. $17.35 2019
Pfizer INC. $16.26 2019
Mdd US Operations, LLC $16.04 2019
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Merz Pharmaceuticals, LLC $15.97 2021
Allergan, INC. $12.84 2019
Lilly USA, LLC $12.32 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James Cochran

$934.17

in general payments reported 2019-2025

Years
2019-2022
Top company
Amgen INC.

https://glasscript.com/doctor/146950/james-cochran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.